Search - tctmd.com

Presenter: Amit Sachdeva, Sumati Bavisetty, Gerald Beckham, Albert Shen, Vicken Aharonian, Prakash Mansukhani, Gregg Stone, Martin Leon, Jeffrey Moses, Naing Moore, Ric Hyett, Richard Contreras, Somjot Brar

January 31, 2013

News Conference News AHA 2012

Evidence Continues to Support Dabigatran Treatment in A-fib

November 06, 2012

News Conference News AHA 2012

No Mortality Benefit with Prolonged Dual Antiplatelet Therapy

November 05, 2012

News Daily News

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

L.A. McKeown

August 09, 2012

News Daily News

Las Directrices Elevan el Ticagrelor a la Categoría de Antiplaquetario de 1ª Línea contra la Angina Inestable

Jason Kahn

July 17, 2012

News Daily News

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Jason Kahn

July 17, 2012

Advertisement

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Meta-analysis Questions One-Size-Fits-All Anticoagulant Strategy in STEMI Patients

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Long-Term Better than Short-Term Prasugrel After PES Stenting

ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders

ISAR-SAFE: Another Randomized Trial Finds 6 Months of DAPT as Good as 12 Months

大多数美国患者在急性心肌梗死后出院时仍被开出高剂量阿司匹林

Majority of US Patients Still Discharged on High-Dose Aspirin After Acute MI

La Mayoría de Pacientes de EE.UU. siguen recibiendo el Alta Hospitalaria con Dosis Altas de Aspirina tras Sufrir un IAM

Michigan Registry Study Finds Pre-PCI Statin Use Not Associated with Better Outcomes

TCTMD’s Top 10 Most Popular News Stories for 2013

TCTMD 2013年10大热门新闻

Discontinuation of Long-Term Clopidogrel Therapy is Associated with Death and Myocardial Infarction after Saphenous Vein Graft Percutaneous Coronary Intervention

Evidence Continues to Support Dabigatran Treatment in A-fib

No Mortality Benefit with Prolonged Dual Antiplatelet Therapy

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

Las Directrices Elevan el Ticagrelor a la Categoría de Antiplaquetario de 1ª Línea contra la Angina Inestable

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content